EMA Finds No Link Between GLP-1 Drugs and Suicidal Thoughts, Self-Harm 4/12/2024

EC Approves Illumina’s Plan to Divest Cancer Diagnostics Maker Grail 4/12/2024

AACR, Cancer Treatment and the Promise of Antibody-Drug Conjugates 4/12/2024

Enlivex’s Stock Plummets 50% on Phase II Sepsis Results for Cell Therapy 4/12/2024

Lilly Suffers Legal Loss in Tirzepatide Case Against Compounding Pharmacy 4/12/2024

AstraZeneca Expands Fasenra’s Label to Younger Children with Severe Asthma 4/12/2024

Fujifilm Pumps $1.2B into CDMO Capacity in North Carolina, Eyes 680 New Jobs by 2031 4/12/2024

Vaccines, Next-Gen Approaches Target the Toughest Cancers: AACR 4/12/2024

CryoEM: Evolution and Best Practices 4/12/2024

AstraZeneca Wins Label Expansion for Severe Asthma Drug in Younger Kids 4/12/2024

Top 5 Companies Hiring in San Diego 4/11/2024

GLP-1s Like Novo Nordisk’s Ozempic Do Not Increase Thyroid Cancer Risk: Study 4/10/2024

AACR: Merck, Kelun’s Anti-TROP2 ADC Shows Early Promise in Gastric Cancer 4/10/2024

TORL Targets Hot ADC Space with Oversubscribed $158M Series B-2 4/10/2024

Birth Control Market Evolves as OTC Opill Hits US Stores 4/10/2024

Can $12 Billion Jumpstart Women’s Health? 4/10/2024

Alphabet Soup: AACR and ACC Dominate Headlines This Week 4/10/2024

YS Biopharma’s Rabies Vaccine Outperforms Commercial Competitor in Phase III Trial 4/10/2024

AACR: Study Suggests Accelerated Approval Doesn’t Always Lead to Clinical Benefit 4/10/2024

7 Billion-Dollar Oncology M&As from Q1 4/10/2024